Skip to content

Raw materials at other companies

Solventum logo
SolventumSOLV
$224M+6.2%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$90.2M-3.3%
AbbVie logo
AbbVieABBV
Globus Medical logo
Globus MedicalGMED
Medtronic logo
MedtronicMDT
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's raw materials?
Establishment Labs (ESTA) reported raw materials of $34.49M in Q1 2026.
How has Establishment Labs's raw materials changed year-over-year?
Establishment Labs's raw materials decreased by 28.3% year-over-year, from $48.13M to $34.49M.
What is the long-term trend for Establishment Labs's raw materials?
Over 5 years (2020 to 2025), Establishment Labs's raw materials has grown at a 45.2% compound annual growth rate (CAGR), from $5.45M to $35.16M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.